ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Prelude Therapeutics Inc

Prelude Therapeutics Inc (PRLD)

1.15
-0.045
(-3.77%)
At close: 13 November 8:00AM
1.15
0.00
( 0.00% )
After Hours: 8:02AM

Prelude Therapeutics Inc Financial Summary

The current PRLD market cap is 63.29M. The company's latest EPS is USD -2.2137 and P/E is -0.52.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -32.4M-33.39M-37.38M-34.34M-37.16M
Net Income -30.43M-30.61M-33.08M-31.43M-34.74M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -28.11M-58.76M-113.74M-123.54M-132.28M
Net Income -27.57M-56.93M-111.69M-115.44M-121.83M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 280.61M258.51M277.67M247.11M224.29M
Total Liabilities 18.55M20.25M40.58M36.37M42.02M
Total Equity 262.06M238.26M237.09M210.73M182.28M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 21.87M223.59M305.1M220.5M277.67M
Total Liabilities 4.84M11.41M19.2M25.06M40.58M
Total Equity -49.41M212.18M285.9M195.44M237.09M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -57.8M-83.49M-107.06M-31.79M-54.85M
Investing -57.43M-42.38M-34.65M31.22M57.34M
Financing 111.07M111.16M136.4M-14k45k
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -25.67M-46.18M-83.53M-83.73M-107.06M
Investing -780k-621k-263.8M81.69M-34.65M
Financing 29.73M246.23M164.9M815k136.4M
Market Cap 63.29M
Price to Earnings Ratio -0.52
Price to Sales Ratio 0
Price to Cash Ratio 2.5
Price to Book Ratio 0.27
Dividend Yield -

Share Statistics

Shares Outstanding 55.04M
Average Volume (1 week) 293.26k
Average Volume (1 Month) 375.79k
52 Week Change -62.05%
52 Week High 6.80
52 Week Low 1.10
Spread (Intraday) 0.05 (4.24%)

Company Info

Company Name Prelude Therapeutics Inc
Address 200 powder mill road
wilmington, delaware 19803
Website https://www.preludetx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock